We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antibodies in Research: The Good, the Bad, and the Validation Epidemic

Article   Apr 29, 2019 | by Anthony Couvillon, Ph.D., Scientific Marketing Project Manager at Cell Signaling Technology

 
Antibodies in Research: The Good, the Bad, and the Validation Epidemic
 
 
 

RELATED ARTICLES

Testing Medicines After Brexit: Upholding High QC Standards for Pharmaceuticals

Article

Maintaining robust quality control standards is a key priority for any commercial industry – but for pharmaceutical manufacturers, it can literally be a matter of life and death. The looming Brexit deadline is likely to be seen as a pivotal moment by those operating in the sector. The prospect of the UK leaving the European Union, and the jurisdiction of the EU’s unified single market for medicine regulation, is creating considerable uncertainty for drugmakers.

READ MORE

Merging With Machines: A Look at Emerging Neuroscience Technologies

Article

In this article we explore how emerging neurotechnologies are taking us from movement-controlled to mind-controlled machines and from machine extensions of ourselves to machines integrated into ourselves.

READ MORE

Technology Networks Explores the CRISPR Revolution: An Interview With Professor Jennifer Doudna, Co-developer of CRISPR Genome Editing Technology

Article

In the second feature of "Technology Networks Explores the CRISPR Revolution", we speak with the world-renowned scientist, Professor Jennifer Doudna, the co-developer of CRISPR genome editing technology.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Diagnostics Drug Discovery Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE